PHARMAC have announced CGM funding for people with Type 1 diabetes from 1 October 2024. More detail to come.Additional information on Diabetes New Zealand website and the Pharmac Websites
You have nothing in your cart.
If you know the product code enter it here
If you know the product code enter it into the search field
Alexa Fluor® 594 anti-LIF, 100 μg
Alexa Fluor® 594 anti-mouse/human Bcl-6, 100 μg
Alexa Fluor® 594 anti-Nanog, 100 μg
Alexa Fluor® 594 anti-Nestin, 100 μg
Alexa Fluor® 594 anti-Nuclear Pore Complex Proteins , 100 μg
Alexa Fluor® 594 anti-Nucleophosmin, 25 μg
Alexa Fluor® 594 anti-Nur77 , 100 μg
Alexa Fluor® 594 anti-OCT4 (OCT3), 100 μg
Alexa Fluor® 594 anti-PARP, 100 μg
Alexa Fluor® 594 anti-RNA Polymerase II RPB1, 100 μg
Alexa Fluor® 594 anti-SATB1, 100 μg
Alexa Fluor® 594 anti-SOX2, 100 μg
Alexa Fluor® 594 anti-SPI1 (PU.1), 100 μg
Alexa Fluor® 594 anti-STAT1 Phospho (Ser727), 25 μg
Alexa Fluor® 594 anti-STAT3 , 100 μg